The issue is not how much cash they have in hand. No matter how much they have now, it will not be enough to complete all the things they want to do. At some point, they need to raise capital. The problem is how they raise capital. They kept doing this ATM #$%$ from small investors. When their drug failed, the share price cannot be supported by large institutional investors, and the share is in a free fall. They need to talk to large institutional investors and give them certain advantage for them to invest in the company. That will also make sure they have certain influence on the management.